17th International Eurasian Pharmaceutical Forum

On 27-28 January 2026, Almaty hosted the 17th International Eurasian Pharmaceutical Forum, a key industry event on the pharmaceutical market of the EAEU and CIS.

As in the previous years, AEQUITAS Law Firm acts as an official partner of the forum.

Larissa Yemelyanova, AEQUITAS Partner and Head of Pharmaceutical Practice, spoke at the forum regarding "Safe promotion" (for more information, please click the link).

Larissa's presentation arranges the issues of complex regulation of medicines promotion from the practical point of view with a focus on the key topical issues, existing risks and gaps in legal environment, as well as on obligations and opportunities of persons involved in circulation of medicines in Kazakhstan.

Larissa also paid attention to topical issues of regulation of digital communications and the use of artificial intelligence systems, anticorruption requirements, expectations of legislative changes, and personal data issues.

Her speech underlined the issues of ensuring balance between efficient marketing and compliance with regulatory requirements on the dynamic pharmaceutical market. Larissa wound up her speech by declaring that the current legal rules on provision of medicines in Kazakhstan objectively need to be reformed.

It is worth mentioning that the speech was prepared subject to long-term and extensive expertise of AEQUITAS in the support of pharmaceutical companies, with profound understanding of the industry specifics and applicable regulation. The issues of promotion of pharmaceutical products are among the most topical in the conditions of price and regulatory pressure on the industry.

AEQUITAS has stable practice of supporting pharmaceutical companies on the issues of regulation, promotion and compliance, and fosters its professional interactions with the pharmaceutical market participants.